What are the complications of vascular interventional treatment for liver cancer? These situations need attention

There will be some complications in vascular interventional treatment of liver cancer. At this time, the patient will have hepatic artery chemoembolization, that is, low fever, chest tightness, etc. If it is hepatic artery damage, it can also be prevented and can have good results.

Patients with liver cancer can choose vascular interventional treatment, which will have better results, but there will be some complications. So, what are the complications of vascular interventional treatment for liver cancer?
The most common interventional treatment for liver cancer patients is transvascular treatment, which is also known as hepatic artery chemoembolization. Patients may experience some complications, most commonly low-grade fever, chest tightness, poor appetite, etc., which are all common post-embolization syndromes. After percutaneous puncture, patients may experience complications such as pneumothorax and bleeding. Some patients may have bile duct damage, and there is a possibility of pain or infection.
Patients may experience hepatic artery damage and liver parenchymal damage, which is caused by damage to the vascular endothelium caused by chemotherapy drugs or the use of catheters. Chemotherapy drugs will damage the patient's liver cells, and the clinical manifestations are thinning of the hepatic artery, and even stenosis or occlusion. During treatment, the specific cannulation depth can be determined based on the patient's blood vessel diameter. Microcatheters can also be used to help reduce damage to thinner hepatic arteries. Superselective cannulation can be used as much as possible to reduce damage to liver tissue.